4541-14-4

Basic information

• Product Name: 4-Benzyloxy-1-butanol
• Synonyms: 4-BENZYLOXY-1-BUTANOL;tetramethylene glycol monobenzyl ether;4-Benzyloxy-1-butanol, 96 %;4-(Benzyloxy)butane-1-ol;4-Benzyloxybutane-1-ol;4-Benzyloxy-1-butanol,97%;4-(Benzyloxy)butan-1-ol;4-Benzyloxy-1-butanol 97%
• CAS NO: 4541-14-4
• Molecular Formula: C₁₁H₁₆O₂
• Molecular Weight: 180.24
• Mol File: 4541-14-4.mol
• Article Data: 146

Chemical Properties

• Boiling Point: 216-256 °C(lit.)
• Flash Point: 109 °C
• Appearance: /
• Density: 1.025 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.00183mmHg at 25°C
• Refractive Index: n20/D 1.513(lit.)
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 15.07±0.10(Predicted)
• BRN: 1944253
• CAS DataBase Reference: 4-Benzyloxy-1-butanol(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Benzyloxy-1-butanol(4541-14-4)
• EPA Substance Registry System: 4-Benzyloxy-1-butanol(4541-14-4)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 4541-14-4(Hazardous Substances Data)

Usage

Description

4-Benzyloxy-1-butanol is a clear colorless liquid that can be synthesized starting from butane-1,4-diol. It is a versatile chemical compound with various applications in different industries.

Uses

Used in Chemical Synthesis:
4-Benzyloxy-1-butanol is used as a starting reagent for the synthesis of 4-(benzyloxy)butanal, which is an important intermediate in the production of various organic compounds.
Used in Pharmaceutical Industry:
4-Benzyloxy-1-butanol is used as a key intermediate in the preparation of ethyl 6-benzyloxy-2-hexenoate, which is an important compound in the pharmaceutical industry. 4-Benzyloxy-1-butanol is synthesized via Swern oxidation and Wadsworth-Emmons olefination, two widely used methods in organic chemistry.

InChI:InChI=1/C11H16O2/c12-8-4-5-9-13-10-11-6-2-1-3-7-11/h1-3,6-7,12H,4-5,8-10H2

Upstream product

• 1927-58-8 2-benzyloxy-tetrahydro-furan 
• 109-99-9 tetrahydrofuran 
• 908094-04-2 phenyldiazomethane 
• 2749-68-0 2-phenyl-[1,3]dioxepane 
• 444816-12-0 (4-benzyloxy-butoxy)-triethyl-silane 
• 100-52-7 benzaldehyde 
• 110-63-4 Butane-1,4-diol 
• 865-47-4 potassium tert-butylate 
• 100-39-0 benzyl bromide 
• 1082056-32-3 Bis(4-methoxyphenyl)methyl 4-benzyloxybutyl ether 
• 1342307-55-4 C₂₀H₃₆O₂Si 
• 728-87-0 4,4'-Dimethoxybenzhydrol 
• 105966-46-9 [4-(benzyloxy)butoxy](tert-butyl)dimethylsilane 
• 81518-74-3 1-benzyloxy-4-pentene 

Downstream Products

• 110-63-4 Butane-1,4-diol 
• 50873-93-3 [(4-chlorobutoxy)methyl]benzene 
• 50873-94-4 (4-iodobutoxymethyl)benzene 
• 105966-45-8 2-[4-(benzyloxy)butoxy]tetrahydro-2H-pyran 
• 613229-92-8 4-Benzyloxycarbonylmethoxy-benzoic acid (2R,3R,4S,5R,6R)-3,4,5-triacetoxy-6-(4-benzyloxy-butoxy)-tetrahydro-pyran-2-ylmethyl ester 
• 746692-58-0 2,2,4,4,6,6-hexakis-(4-benzyloxy-butoxy)-2λ⁵,4λ⁵,6λ⁵-[1,3,5,2,4,6]triazatriphosphinine 
• 380365-04-8 Diphenylmethyl 4-benzyloxybutyl ether 
• 891769-89-4 2-amino-5-(3-benzyloxyethyl)-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-thione 
• 319458-60-1 2-amino-5-[2-(benzyloxy)ethyl]-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one 
• 752235-78-2 tert-butyl N-(4-benzyloxybutoxycarbonyl)-3-({[(5R)-3-(4-cyanophenyl)-4,5-dihydro-5-isoxazolyl]acetyl}amino)-L-alaninate 
• 752235-81-7 3-{[((5R)-3-{4-[(acetyloxyamino)(imino)methyl]phenyl}-4,5-dihydro-5-isoxazolyl)acetyl]amino}-N-(4-benzyloxybutoxycarbonyl)-L-alanine 
• 752235-79-3 tert-butyl N-(4-benzyloxybutoxycarbonyl)-3-{[((5R)-3-{4-[(hydroxyamino)(imino)methyl]phenyl}-4,5-dihydro-5-isoxazolyl)acetyl]amino}-L-alaninate 
• 752235-80-6 tert-butyl 3-{[((5R)-3-{4-[(acetyloxyamino)(imino)methyl]phenyl}-4,5-dihydro-5-isoxazolyl)acetyl]amino}-N-(4-benzyloxybutoxycarbonyl)-L-alaninate 
• 541515-89-3 (4R)-4-benzyl-3-[(2R,3S)-6-benzyloxy-3-hydroxy-2-methylhexanoyl]oxazolidin-2-one 

Relevant articles and documents

Tandem vinylcyclopropane ring opening/Prins cyclization for the synthesis of 2,3-disubstituted tetrahydropyrans

An efficient synthesis of 2,3-disubstituted tetrahydropyrans from aldehyde and cyclopropyl alkenol has been accomplished using HBF4·OEt2 as a promoter through a tandem vinylcyclopropane ring-opening/Prins cyclization. It is a convenient process to generate a structurally diverse and biologically relevant 2,3-disubstituted tetrahydropyrans in good yields with high selectivity.

Composition for controlling pine wood nematode containing benzyloxyalcohol

The present invention relates to a composition for controlling pine nematode comprising a benzyloxyalcohol compound and a method for controlling pine nematode using the same.

Manganese=Catalyzed Achmatowicz Rearrangement Using Green Oxidant H2O2

Oxidation reactions have been extensively studied in the context of the transformations of biomass=derived furans. However, in contrast to the vast literature on utilizing the stoichiometric oxidants, such as m=CPBA and NBS, catalytic methods for the oxidative furan=recyclizations remain scarcely investigated. Given this, we report a means of manganese=catalyzed oxidations of furan with low loading, achieving the Achmatowicz rearrangement in the presence of hydrogen peroxide as an environmentally benign oxidant under mild conditions with wide functional group compatibility.

Synthesis of salicylate and salicylamide alcohols for the preparation of phosphorodiamidates and ifosfamide prodrugs

Prodrugs are derivatives of drugs which gives parent drug or release drug when it breaks inside the body by the presence of suitable enzyme, and then exert desired pharmacological effect. For many years, prodrug strategy has been developed enormously to solve many unwanted drug properties. In drug discovery and development, prodrugs have well-known pharmacokinetic effects of pharmacologically nimble products. Almost 10% of drugs permitted whole world are classified as prodrugs, where the application of a prodrug method during initial stages of development is an emergent fashion. Phosphorodiamidates prodrugs are well known anticancer agents particularly against leucomia. To improve the selectivity of the chemotherapeutic agents and reduce systemic toxicity, I herein report different types of salicylate and salicylamide alcohols for the preparation of phosphorodiamidates and ifosfamide prodrugs.